Blockade of the T cell immunoglobulin and mucin domain protein 3 pathway exacerbates sepsis-induced immune deviation and immunosuppression

Clinical and Experimental Immunology

Volumn 178, Issue 2, 2014, Pages 279-291

  Zhao, Z ^a,c,d   Jiang, X ^a   Kang, C ^b   Xiao, Y ^b   Hou, C ^a   Yu, J ^c   Wang, R ^a   Xiao, H ^a   Zhou, T ^a   Wen, Z ^b   Feng, J ^a   Chen, G ^a   Ma, Y ^c   Shen, B ^a   Li, Y ^a   Han, G ^a  

^a Basic Medical Research Institute   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c HENAN UNIVERSITY   (China)

^d ZHENGZHOU PEOPLE S HOSPITAL   (China)

Author keywords

Macrophage; Sepsis; T helper cell; Tim 3

Indexed keywords

HAVCR2 PROTEIN, HUMAN; HYBRID PROTEIN; MEMBRANE PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL LINE; DISEASE MODEL; DRUG EFFECTS; GENE SILENCING; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTE; MACROPHAGE; MALE; METABOLISM; MORTALITY; MOUSE; SEPSIS; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; APOPTOSIS; CELL LINE; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOMODULATION; IMMUNOPHENOTYPING; LYMPHOCYTES; MACROPHAGES; MALE; MEMBRANE PROTEINS; MICE; RECOMBINANT FUSION PROTEINS; SEPSIS; SIGNAL TRANSDUCTION; SINGLE-CHAIN ANTIBODIES; TH2 CELLS;

EID: 84908162241     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12401     Document Type: Article

References (38)

1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369:840-851.
2. Gustot T. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care 2011; 17:153-159.
3. Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009; 15:496-497.
4. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013; 13:260-268.
5. Venet F, Lukaszewicz AC, Payen D, Hotchkiss R, Monneret G. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol 2013; 25:477-483.
6. Cohen HB, Mosser DM. Extrinsic and intrinsic control of macrophage inflammatory responses. J Leukoc Biol 2013; 94:913-919.
7. Biswas SK, Chittezhath M, Shalova IN, Lim JY. Macrophage polarization and plasticity in health and disease. Immunol Res 2012; 53:11-24.
8. Pena OM, Pistolic J, Raj D, Fjell CD, Hancock RE. Endotoxin tolerance represents a distinctive state of alternative polarization (M2) in human mononuclear cells. J Immunol 2011; 186:7243-7254.
9. Sundar KM, Sires M. Sepsis induced immunosuppression: implications for secondary infections and complications. Indian J Crit Care Med 2013; 17:162-1693.
10. O'Sullivan ST, Lederer JA, Horgan AF, Chin DHL, Mannick JA, Rodrick ML. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995; 222:482-490.
11. Neidhardt R, Keel M, Steckholzer U etal. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 1997; 42:863-870.
12. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev 2003; 8:223-246.
13. Sanchez-Fueyo A, Tian J, Picarella D etal. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003; 4:1093-1101.
14. Shi F, Guo X, Jiang X etal. Dysregulated Tim-3 expression and its correlation with imbalanced CD4 helper T cell function in ulcerative colitis. Clin Immunol 2012; 145:230-240.
15. Wu W, Shi Y, Li S etal. Blockade of Tim-3 signaling restores the virus-specific CD8? T-cell response in patients with chronic hepatitis B. Eur J Immunol 2012; 42:1180-1191.
16. Liberal R, Grant CR, Holder BS etal. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/Tim-3 pathway. Hepatology 2012; 56:677-686.
17. Anderson AC. Tim-3, a negative regulator of anti-tumor immunity. Curr Opin Immunol 2012; 24:213-216.
18. Monney L, Sabatos CA, Gaglia JL etal. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002; 415:536-541.
19. Frisancho-Kiss S, Nyland JF, Davis SE etal. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol 2006; 176:6411-6415.
20. Yang X, Jiang X, Chen G etal. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response. J Immunol 2013; 190:2068-2079.
21. Dardalhon V, Anderson AC, Karman J etal. Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J Immunol 2010; 185:1383-1392.
22. Kim SD, Kim HJ, Shim JW etal. Phospholipase C activator m-3M3FBS protects against morbidity and mortality associated with sepsis. J Immunol 2012; 189:2000-2005.
23. Li Y, Fenga J, Genga S etal. The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity. Mol Immunol 2011; 48:670-677.
24. Uchida Y, Ke B, Freitas MC etal. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology 2010; 139:2195-2206.
25. Sansom DM, Manzotti CN, Zheng Y. What's the difference between CD80 and CD86? Trends Immunol 2003; 24:313-318.
26. Wagner CJ, Huber S, Wirth S, Voehringer D. Chitin induces upregulation of B7-H1 on macrophages and inhibits T-cell proliferation. Eur J Immunol 2010; 40:2882-2890.
27. Benoit M, Barbarat B, Bernard A, Olive D, Mege JL. Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages. Eur J Immunol 2008; 38:1065-1070.
28. Kadowaki T, Morishita A, Niki T etal. Galectin-9 prolongs the survival of septic mice by expanding tim-3-expressing natural killer T cells and PDCA-1+ CD11c+ macrophages. Crit Care 2013; 17:R284.
29. Meng W, Paunel-Görgülü A, Flohé S etal. Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice. Crit Care 2012; 16:R137.
30. Hirsh M, Kaplan V, Dyugovskaya L etal. Response of lung NK1.1-positive natural killer cells to experimental sepsis in mice. Shock 2004; 22:40-45.
31. Murphey ED, Herndon DN, Sherwood ER. Gamma interferon does not enhance clearance of Pseudomonas aeruginosa but does amplify a proinflammatory response in a murine model of postseptic immunosuppression. Infect Immun 2004; 72:6892-6901.
32. Nathan CF, Murray HW, Wiebe ME, Rubin BY. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and anti-microbial activity. J Exp Med 1983; 158:670-689.
33. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 1992; 176:287-292.
34. Shnyra AA, Brewington R, Alipio A, Amura C, Morrison DC. Reprogramming of LPS-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J Immunol 1998; 160:3729-3736.
35. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3:23-35.
36. Fiorentino DF, Zlotnik A, Vieira P etal. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146:3444-3451.
37. Hotchkiss RS, Swanson PE, Freeman BD etal. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 1999; 27:1230-1251.
38. Essa S, Raghupathy R, Pacsa AS etal. Th1-type cytokines production is decreased in kidney transplant recipients with active cytomegalovirus infection. J Med Virol 2000; 60:223-229.